Analyst Price Target is $14.25
▲ +74.21% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Waldencast in the last 3 months. The average price target is $14.25, with a high forecast of $15.50 and a low forecast of $13.00. The average price target represents a 74.21% upside from the last price of $8.18.
Current Consensus is
The current consensus among 3 investment analysts is to moderate buy stock in Waldencast. This Moderate Buy consensus rating has held steady for over two years.
Waldencast plc, a skincare company, develops, markets, and sells skin health products worldwide. The company offers approximately 200 cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force; and through distribution partners. The company was founded in 1988 and is based in White Plains, New York.